Zhang Xinling, Gao Xuejie, Wei Yaqi, Zhang Yi, Zhang Kun, Chen Hongtao, Han Lu, Mu Mengxin, Ji Chendong, Zhao Hongyi
Department of Plastic Surgery, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, NO.1 Dahua Road, Dongdan, Beijing, 100730, China.
Beijing Engineering Lab of Neo-Biodegradable Materials, Beijing, 102299, China.
Photodiagnosis Photodyn Ther. 2025 Aug;54:104647. doi: 10.1016/j.pdpdt.2025.104647. Epub 2025 May 24.
OBJECTIVE: To explore the efficacy and safety of pulsed laser-activated injectable hydrogel for combined photodynamic and photothermal therapy of hypertrophic scars. METHODS: In this prospective study, indocyanine green (ICG) was used as a photosensitizer combined with hyaluronic acid (HA) to prepare ICG-HA hydrogel, and its photodynamic and photothermal properties were evaluated. The ex vivo photothermal experiments were conducted to assess the thermal effects on tissue integrity as a preliminary evaluation of safety. Human umbilical vein endothelial cells (HUVECs) were used as the experimental cell model to evaluate the in vitro effects of ICG-HA hydrogel under different therapies. A rabbit ear scar model (n = 36) was established and randomly divided into 6 groups: ICG-HA hydrogels + single-pulse irradiation, single-pulse irradiation, ICG-HA hydrogels + continuous-pulse irradiation, continuous-pulse irradiation, ICG-HA hydrogels and control (n = 6/group). Scar characteristics were monitored at 0, 1, 3, and 5 weeks using Ultrasound Doppler, colorimetry, VSS, and SEI assessments. At 1 and 5 weeks after ICG-HA hydrogels injection, histopathological analyses (hematoxylin and eosin (HE) staining, Masson's trichrome staining (MASSON) and CD31 immunohistochemical staining) were performed. RESULTS: The ICG-HA hydrogel exhibited favorable photodynamic and photothermal properties while maintaining structural integrity during laser therapy. In vitro cell experiments, using CCK-8 for metabolic activity and live/dead staining for membrane integrity, demonstrated that the combined PDT and PTT treatment significantly reduced cell metabolic activity and induced cell death compared to either PDT or PTT alone (P < 0.001). In the rabbit ear scar model, the VSS results showed that at 3 and 5 weeks post-treatment, both the ICG-HA hydrogels + single-pulse irradiation group and the ICG-HA hydrogels + continuous-pulse irradiation group had significantly lower VSS scores compared to the control group (P < 0.05), with the ICG-HA hydrogels + single-pulse irradiation group showing a more pronounced reduction (P < 0.01 at 3 weeks and P < 0.001 at 5 weeks). The similar trends were observed in the SEI scores. Colorimeter analysis revealed that, compared with the control group and the single-pulse irradiation group, the ICG-HA hydrogels + single-pulse irradiation group exhibited significantly lower color difference scores at 1, 3, and 5 weeks post-treatment (P < 0.001, P < 0.01 and P < 0.001, respectively). HE staining results showed that, at 1 and 5 weeks post-treatment, the ICG-HA hydrogels + single-pulse irradiation group had the most significant reduction in scar thickness compared with all other groups (P < 0.001). MASSON results indicated that, at 1 week post-treatment, the ICG-HA hydrogels + single-pulse irradiation group exhibited more orderly collagen alignment with significant consistency and sparser collagen distribution. CD31 immunohistochemical staining results demonstrated that, at 1 and 5 weeks post-treatment, the ICG-HA hydrogels + single-pulse irradiation group significantly reduced vascular density within the scar tissue (P < 0.001). CONCLUSIONS: The ICG-HA hydrogel can effectively and safely synergize PDT and PTT to improve hypertrophic scar conditions under pulsed laser irradiation, especially single-pulse irradiation. This approach provides valuable reference for the clinical treatment in scar treatment.
目的:探讨脉冲激光激活可注射水凝胶在肥厚性瘢痕联合光动力和光热治疗中的疗效及安全性。 方法:在这项前瞻性研究中,吲哚菁绿(ICG)与透明质酸(HA)联合用作光敏剂制备ICG-HA水凝胶,并评估其光动力和光热性能。进行体外光热实验以评估对组织完整性的热效应,作为安全性的初步评估。使用人脐静脉内皮细胞(HUVECs)作为实验细胞模型,评估ICG-HA水凝胶在不同治疗下的体外效应。建立兔耳瘢痕模型(n = 36),随机分为6组:ICG-HA水凝胶+单脉冲照射、单脉冲照射、ICG-HA水凝胶+连续脉冲照射、连续脉冲照射、ICG-HA水凝胶和对照组(每组n = 6)。在第0、1、3和5周使用超声多普勒、比色法、温哥华瘢痕量表(VSS)和瘢痕弹性指数(SEI)评估监测瘢痕特征。在注射ICG-HA水凝胶后1周和5周进行组织病理学分析(苏木精和伊红(HE)染色、Masson三色染色(MASSON)和CD31免疫组织化学染色)。 结果:ICG-HA水凝胶在激光治疗期间表现出良好的光动力和光热性能,同时保持结构完整性。体外细胞实验中,使用CCK-8检测代谢活性和活/死染色检测膜完整性,结果表明与单独的光动力疗法(PDT)或光热疗法(PTT)相比,联合PDT和PTT治疗显著降低细胞代谢活性并诱导细胞死亡(P < 0.001)。在兔耳瘢痕模型中,VSS结果显示,在治疗后3周和5周,ICG-HA水凝胶+单脉冲照射组和ICG-HA水凝胶+连续脉冲照射组的VSS评分均显著低于对照组(P < 0.05),其中ICG-HA水凝胶+单脉冲照射组降低更为明显(3周时P < 0.01,5周时P < 0.001)。SEI评分也观察到类似趋势。比色法分析显示,与对照组和单脉冲照射组相比,ICG-HA水凝胶+单脉冲照射组在治疗后1周、3周和5周的色差评分显著更低(分别为P < 0.001、P < 0.01和P < 0.001)。HE染色结果显示,在治疗后1周和5周,ICG-HA水凝胶+单脉冲照射组的瘢痕厚度与所有其他组相比降低最为显著(P < 0.001)。MASSON结果表明,在治疗后1周,ICG-HA水凝胶+单脉冲照射组的胶原排列更有序,具有显著的一致性且胶原分布更稀疏。CD31免疫组织化学染色结果表明,在治疗后1周和5周,ICG-HA水凝胶+单脉冲照射组显著降低瘢痕组织内的血管密度(P < 0.001)。 结论:ICG-HA水凝胶可有效且安全地协同PDT和PTT,在脉冲激光照射下,尤其是单脉冲照射下改善肥厚性瘢痕状况。该方法为瘢痕治疗的临床治疗提供了有价值的参考。
Cochrane Database Syst Rev. 2022-9-26
Cochrane Database Syst Rev. 2025-6-16
Cochrane Database Syst Rev. 2024-1-8
Cochrane Database Syst Rev. 2016-4-3
Cochrane Database Syst Rev. 2016-12-15
Cochrane Database Syst Rev. 2007-1-24